NewEdge Wealth’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $976K | Sell |
7,435
-407
| -5% | -$53.4K | 0.02% | 539 |
|
|
2025
Q1 | $1M | Buy |
7,842
+312
| +4% | +$39.9K | 0.02% | 483 |
|
|
2024
Q4 | $996K | Sell |
7,530
-1,110
| -13% | -$147K | 0.02% | 488 |
|
|
2024
Q3 | $1.26M | Buy |
8,640
+1,965
| +29% | +$286K | 0.02% | 432 |
|
|
2024
Q2 | $916K | Sell |
6,675
-1,587
| -19% | -$218K | 0.02% | 431 |
|
|
2024
Q1 | $1.08M | Sell |
8,262
-232
| -3% | -$30.3K | 0.02% | 416 |
|
|
2023
Q4 | $1.15M | Buy |
8,494
+5,129
| +152% | +$697K | 0.03% | 377 |
|
|
2023
Q3 | $411K | Sell |
3,365
-315
| -9% | -$38.5K | 0.01% | 483 |
|
|
2023
Q2 | $467K | Sell |
3,680
-441
| -11% | -$56K | 0.02% | 465 |
|
|
2023
Q1 | $532K | Buy |
4,121
+34
| +0.8% | +$4.39K | 0.02% | 402 |
|
|
2022
Q4 | $537K | Buy |
4,087
+1,245
| +44% | +$163K | 0.02% | 358 |
|
|
2022
Q3 | $332K | Buy |
2,842
+200
| +8% | +$23.4K | 0.02% | 409 |
|
|
2022
Q2 | $311K | Sell |
2,642
-7,803
| -75% | -$919K | 0.01% | 458 |
|
|
2022
Q1 | $1.36M | Buy |
10,445
+7,858
| +304% | +$1.02M | 0.06% | 193 |
|
|
2021
Q4 | $395K | Buy |
+2,587
| New | +$395K | 0.02% | 316 |
|